H2H Safer Supply & Harm Reduction Research

The H2H supervised consumption site and safer supply programs are innovative harm reduction interventions based in the downtown east side of Vancouver. We have developed a mixed-methods evaluation for these programs in order to generate new knowledge around the impact of these programs on clinical, therapeutic and psychosocial outcomes of clients. Our leadership will continue to generate meaningful action from new knowledge and science.

Data

  • Qualitative interviews
  • Prospective cohort of clients
  • Clinical monitoring and evaluation

Start Date

November 2021

Funding (Health Canada 2019-2023)

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below